Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of CoronaVac in Children and Adolescents (3-17 Years)
NCT04992208Phase 4Completed
- Sponsor
- Sinovac Life Sciences
- Start
- Jul 2021
- Primary completion
- Mar 2023
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of coronavac in coronavirus disease 2019 (COVID-19), sponsored by Sinovac Life Sciences. Started Jul 2021; status: completed.
02
Drugs
coronavac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04992208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04992208.